The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Cullinan Therapeutics Inc (NASDAQ: CGEM) closed at $17.95 in the last session, up 1.87% from day before closing price of $17.62. In other words, the price has increased by $1.87 from its previous closing price. On the day, 0.51 million shares were traded. CGEM stock price reached its highest trading level at $18.55 during the session, while it also had its lowest trading level at $17.44.
Ratios:
We take a closer look at CGEM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 28.87 and its Current Ratio is at 28.87. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 01, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $30.Wedbush initiated its Outperform rating on February 15, 2024, with a $30 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 05 ’24 when Michaelson Jennifer sold 8,000 shares for $18.09 per share. The transaction valued at 144,720 led to the insider holds 115,942 shares of the business.
JENNIFER MICHAELSON & MARC D M bought 16,000 shares of CGEM for $298,880 on Sep 05 ’24. On Jul 05 ’24, another insider, Michaelson Jennifer, who serves as the Chief Scientific Officer of the company, sold 8,000 shares for $16.33 each. As a result, the insider received 130,640 and left with 123,942 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 1040680000 and an Enterprise Value of 380919712.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is 0.29%, while the 200-Day Moving Average is calculated to be 4.88%.
Shares Statistics:
According to the various share statistics, CGEM traded on average about 781.06K shares per day over the past 3-months and 510810 shares per day over the past 10 days. A total of 42.90M shares are outstanding, with a floating share count of 38.58M. Insiders hold about 33.46% of the company’s shares, while institutions hold 77.55% stake in the company. Shares short for CGEM as of 1724976000 were 8047499 with a Short Ratio of 10.30, compared to 1722384000 on 8355333. Therefore, it implies a Short% of Shares Outstanding of 8047499 and a Short% of Float of 16.1.
